Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Skin 08. October 2026
Search
medline.ch
Skin
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 7257  Previews Next
   
   Articles 1 - 20 / 145127  
   
Current and emerging strategies for the management of brain and leptomeningeal metastases in melanoma.
Front Oncol
Idoudi S, Billard K, Ezine E, Fournier M, Norri N, Decq P, Goutagny S, Nataf F, Lebbé C, Faillot M.
PMID: 42840607 [PubMed]


Five-Year Survival Analyses on Non-Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Regimens Plus Surgery: A Propensity Score Matching, Real-World Cohort Study.
Cancer Med
Liu W, Deng Y, Lin Y, Lin Y, Zheng X, Su W, Xiao W, Shi Y, Zhang J, Chen X.
PMID: 42839363 [PubMed - indexed for MEDLINE]


Same-day diagnosis and robotic resection of rare primary pulmonary melanoma: a robotic bronchoscopy-guided approach.
BMJ Case Rep
Fontaine-Nicola A, Manueli Laos EG, Masrur MA, Kovitz KL, David O, Abdelhady K.
PMID: 42838699 [PubMed - indexed for MEDLINE]


The canine tumour micro-environment and advances in antitumour therapy in canine melanoma.
Vet J
Hindriks E, Mmjm Z, Ajam S, Broere F.
PMID: 42838287 [PubMed - as supplied by publisher]


Explainable AI framework for skin lesion imaging based cancer detection.
PLoS One
Tera SP, Chinthaginjala R, Natha P, Srinivasulu A, Al-Turjman F, Mohammad F.
PMID: 42837382 [PubMed - indexed for MEDLINE]


First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306).
Nat Commun
Yoon HH, Kato K, Raymond E, Hubner R, Shu Y, Pan Y, Park SR, Kojima T, Lin CY, Wyrwicz L, Tougeron D, Ishihara R, Wang K, Peng Y, Xu J.
PMID: 42834033 [PubMed - indexed for MEDLINE]


Poliosis predicts durable response to immune-checkpoint blockade in metastatic melanoma: a multicenter cohort study.
J Immunother Cancer
Brekner A, Mengoni M, Kött J, Lang BM, Lepper A, Veeser J, Dietzel J, Laubach N, Forschner A, Gebhardt C, Grabbe S, Stege H, Haist M.
PMID: 42833860 [PubMed - indexed for MEDLINE]


SkinFusionNet: Multi-backbone spatial fusion for robust and explainable melanoma classification.
Photodiagnosis Photodyn Ther
Ahmmed F, Rafsan RS, Mansib M, Akther A, Esika AE, Mohaimen-Bin-Noor.
PMID: 42833605 [PubMed - as supplied by publisher]


EffAtt-LungNet: An attention-guided EfficientNet framework for three-class lung histopathology classification.
PLoS One
Jamil MA, Awan MDA, Bukhari F, Missen MMS, Kajla NI.
PMID: 42832554 [PubMed - indexed for MEDLINE]


Beyond reduced intake: tumor metabolism and immune dysregulation drive cancer-related malnutrition in head and neck squamous cell carcinoma (HNSCC).
Support Care Cancer
Zurlo V, Piccirillo A, Marciano ML, Pontone M, Rampetta FR, Perri E, Perri F.
PMID: 42832090 [PubMed - indexed for MEDLINE]


Melanoma Recurrence Prediction Using a Tissue-Free Epigenomic Molecular Residual Disease Assay: a Multicenter Prospective Observational Study (COSMOS-MEL01).
Cancer Res Commun
Nakamura Y, Namikawa K, Ogata D, Nakano E, Komada A, Takahashi A, Yoshikawa S, Notake C, Mitani R, Yoshino T.
PMID: 42831872 [PubMed - as supplied by publisher]


Concordance of p16 status between US-guided core needle biopsy and surgical specimens in oropharyngeal squamous cell carcinoma: A diagnostic accuracy study.
Medicine (Baltimore)
Lee D, Choi YJ, Song JS, Lee YS, Chung SR, Baek JH, Lee JH.
PMID: 42826333 [PubMed - indexed for MEDLINE]


Usefulness of 18F-fluorodeoxyglucose positron emission tomography for T1 esophageal squamous cell carcinoma.
Medicine (Baltimore)
Ryu DG, Choi CW, Kim SJ, Kim SJ, Park SB, Jang JO, Lee CM, Son BS.
PMID: 42826281 [PubMed - indexed for MEDLINE]


Biopsy Type and Metastatic Recurrence in Melanoma: A Cohort Study.
J Drugs Dermatol
QingYin M, Yu F, Umair MM, QingLan P, JiYin G, HaiYan D, JinPing Z, Yun C, YuanBo X.
PMID: 42826144 [PubMed - indexed for MEDLINE]


Anti-PD-1 Therapy and Long-Term Toxic Effects Among Patients With Melanoma.
JAMA Netw Open
Kankaria RA, Fankhauser R, Boutros A, Pinzon M, Bai K, Chen SC, Agbisit CB, Kalyan A, Lawless A, Long GV, Sullivan RJ, Mehnert JM, Rapisuwon S, Balko JM, Carlino MS, Menzies AM, Johnson DB.
PMID: 42826021 [PubMed - indexed for MEDLINE]


Melanoma Self-Detection is Not Melanoma Diagnosis: Rethinking the Role of Self-Skin Examination.
J Cancer Educ
De Giorgi V, Cecchi G, Perillo G, Fazzari F, Zuccaro B.
PMID: 42825873 [PubMed - as supplied by publisher]


Salivary metabolic profile in patients with oral squamous cell carcinoma and potentially malignant disorders.
Clin Oral Investig
Soiniemi L, Hyvärinen E, Mikkonen J, Jäsberg H, Kashyap B, Kullaa A.
PMID: 42825825 [PubMed - indexed for MEDLINE]


Targeting VISTA as a novel immunotherapy for skin cancer.
Front Immunol
Hou Y, Chen X, Chen C.
PMID: 42824772 [PubMed - indexed for MEDLINE]


Cancer immunoediting in the melanoma tumor microenvironment: from immune elimination to therapeutic resistance.
Front Immunol
Yan X, Zhang Q, Chen Z, Zhou H.
PMID: 42824519 [PubMed - indexed for MEDLINE]


Nanocarrier-based drug delivery systems for remodeling the melanoma tumor microenvironment.
J Drug Target
Wang H, Sun Y, Wang H, Shen W, Ren G, Wang M.
PMID: 42823820 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 145127    Page 1 of 7257  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1